S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY

ABSTRACT:

SUBMITTER: Della Porta M 

PROVIDER: S-EPMC10428433 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature